Qualia NAD⁺ Formulations for Intracellular NAD⁺ Levels
This study is testing two different dietary supplements, Qualia NAD⁺ version 1 and Qualia NAD⁺ version 2, to see how they affect NAD⁺ levels inside your cells. NAD⁺ (nicotinamide adenine dinucleotide) is a molecule important for many body functions. We are looking for healthy adults between 35 and 75 years old to participate. You would take two capsules daily for 28 days. The main goal is to see if either Qualia NAD⁺ version 1 or Qualia NAD⁺ version 2 can increase your intracellular NAD⁺ levels compared to a placebo (rice flour). The study is currently unclear on its recruitment status, but plans to enroll about 180 people.
- Study design
- This is a randomized, double-blind, placebo-controlled study with about 180 participants. You would be assigned to one of three groups: Qualia NAD⁺ version 1, Qualia NAD⁺ version 2, or a placebo.
- What's involved
- You would take two capsules daily for 28 days. You will also complete questionnaires and provide blood samples using an at-home finger-stick kit at the beginning and end of the study.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary outcome is measured at 28 days, which is the end of the treatment period.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Comparison of Two Qualia NAD⁺ Formulations on Intracellular NAD⁺ Levels
At a glance
Conditions
NCT07132801
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Qualia Life Sciences
Carlsbad, Californiastudy coordinator listed
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Between-group change in intracellular NAD⁺ levels28 days
To assess between-group differences in the change in intracellular NAD⁺ levels from baseline to Week 4 following supplementation with Qualia NAD version 1, Qualia NAD version 2, or placebo.